4/A//SEC Filing
Haigh Adrian 4/A
Accession 0001415889-24-011584
CIK 0001211583other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 4:10 PM ET
Size
7.5 KB
Accession
0001415889-24-011584
Insider Transaction Report
Form 4/AAmended
Haigh Adrian
Director
Transactions
- Exercise/Conversion
Common Shares
2024-04-16$2.31/sh+22,222$51,333→ 44,444 total - Exercise/Conversion
Common Shares
2024-04-15$2.31/sh+22,222$51,333→ 22,222 total
Footnotes (2)
- [F1]On April 16, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 15, 2024, and an additional 22,222 common shares on April 16, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".
- [F2]On April 16, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 15, 2024, and an additional 22,222 common shares on April 16, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001717425
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 4:10 PM ET
- Size
- 7.5 KB